Home Clinical trials For patients Ovary BGOG-ov84/TroFuse-022

BGOG-ov96/RAINFOL-04

A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum- Sensitive Ovarian Cancer (PSOC)

Open
Trial drug
Rinatabart Sesutecan (Rina-S)
Grade
High grade
Prior lines
1
Histology
Serous, Endometrioid
Platin
Platinum sensitive
Phase
III

Treatment

Rinatabart Sesutecan (Rina-S) Plus Standard of Care versus Standard of Care as maintenance therapy.

Treatment duration

The treatment can continue until disease progression, unacceptable toxicities or until you decide to stop.

Contact

To be able to give you the best information and care we do not give medical advice via mail. We kindly ask you to make an appointment via lgog@uzleuven.be.